Atlas Trials

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

Clinical trial NCT00855413 · TERMINATED

Trial details

NCT number
NCT00855413
Sponsor
University of North Carolina, Chapel Hill
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Acute HIV InfectionHIV Infections
Start date
2009-03-01
Primary completion
2013-11-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.